Equal care for the elderly with low-grade gliomas?

A. Pruitt,J. Henson
DOI: https://doi.org/10.1212/WNL.0b013e3181c67882
IF: 9.9
2009-12-15
Neurology
Abstract:Major prognostic factors for adult patients with primary brain tumors of the astrocytic and oligodendroglial series include age, resectability, physical condition, and histopathologic grade.1 With a peak age incidence of 53 years, glioblastoma multiforme (GBM) is relatively common among older patients, and compared to their younger counterparts, the tumors of older patients are more likely to have genetic changes consistent with “primary” GBM rather than low-grade glioma evolving to GBM; furthermore, older patients have a substantially worse prognosis.2,3 Due to their shorter survival, older patients are often treated with abbreviated courses of radiation therapy. Concurrent and adjuvant chemotherapy with temozolomide confers little benefit in older patients when added to irradiation.4 On the brighter side, the VEGF inhibitor bevacizumab appears to be more active against the GBMs of older patents.5 Low-grade (grade II/IV) gliomas (LGG) have a peak age incidence of 34 years, and due to their relative rarity in older patients, our …
What problem does this paper attempt to address?